KR102857084B1 - 그램-음성 박테리아 감염, 오염 및 부착물의 예방 및 처리를 위한 신규한 피리미딘 유도체 - Google Patents
그램-음성 박테리아 감염, 오염 및 부착물의 예방 및 처리를 위한 신규한 피리미딘 유도체Info
- Publication number
- KR102857084B1 KR102857084B1 KR1020217037606A KR20217037606A KR102857084B1 KR 102857084 B1 KR102857084 B1 KR 102857084B1 KR 1020217037606 A KR1020217037606 A KR 1020217037606A KR 20217037606 A KR20217037606 A KR 20217037606A KR 102857084 B1 KR102857084 B1 KR 102857084B1
- Authority
- KR
- South Korea
- Prior art keywords
- difluorophenyl
- cyclopropyl
- amine
- purin
- propylthio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/713—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19170003 | 2019-04-18 | ||
| EP19170003.8 | 2019-04-18 | ||
| EP19188639.9 | 2019-07-26 | ||
| EP19188639 | 2019-07-26 | ||
| PCT/EP2020/060819 WO2020212553A1 (en) | 2019-04-18 | 2020-04-17 | New pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20220003556A KR20220003556A (ko) | 2022-01-10 |
| KR102857084B1 true KR102857084B1 (ko) | 2025-09-10 |
Family
ID=70480222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217037606A Active KR102857084B1 (ko) | 2019-04-18 | 2020-04-17 | 그램-음성 박테리아 감염, 오염 및 부착물의 예방 및 처리를 위한 신규한 피리미딘 유도체 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12318388B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3955929B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7588859B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102857084B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113329753B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020258017B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021012834A2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3955929T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2981773T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020212553A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3527571A1 (en) * | 2018-02-14 | 2019-08-21 | Université de Liège | Pyrimidine derivatives for prevention and treatment of bacterial infection |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018046174A1 (en) | 2016-09-09 | 2018-03-15 | Universite De Liege | New use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4928399A (en) * | 1998-07-27 | 2000-02-21 | M & M Laboratory Co., Ltd. | Ion complex, coating material, and coating method |
| WO2004021979A2 (en) * | 2002-09-06 | 2004-03-18 | Smithkline Beecham Corporation | PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
| DE102005060690B4 (de) * | 2005-12-15 | 2008-09-25 | Capsulution Nanoscience Ag | Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen |
| WO2009034386A1 (en) | 2007-09-13 | 2009-03-19 | Astrazeneca Ab | Derivatives of adenine and 8-aza-adenine and uses thereof-796 |
| EP2236158A1 (en) * | 2009-03-30 | 2010-10-06 | Pharnext | New therapeutic approaches for treating neuroinflammatory conditions |
| WO2010118367A2 (en) * | 2009-04-10 | 2010-10-14 | Progenics Pharmaceuticals, Inc. | Antiviral pyrimidines |
| EP3527571A1 (en) | 2018-02-14 | 2019-08-21 | Université de Liège | Pyrimidine derivatives for prevention and treatment of bacterial infection |
| GB201910656D0 (en) | 2019-07-25 | 2019-09-11 | Univ Liege | New use of triazolo(4,5-d)Pyrimidine deerivatives |
-
2020
- 2020-04-17 BR BR112021012834-4A patent/BR112021012834A2/pt unknown
- 2020-04-17 CN CN202080010314.3A patent/CN113329753B/zh active Active
- 2020-04-17 WO PCT/EP2020/060819 patent/WO2020212553A1/en not_active Ceased
- 2020-04-17 EP EP20717066.3A patent/EP3955929B1/en active Active
- 2020-04-17 DK DK20717066.3T patent/DK3955929T3/da active
- 2020-04-17 ES ES20717066T patent/ES2981773T3/es active Active
- 2020-04-17 KR KR1020217037606A patent/KR102857084B1/ko active Active
- 2020-04-17 AU AU2020258017A patent/AU2020258017B2/en active Active
- 2020-04-17 JP JP2021561852A patent/JP7588859B2/ja active Active
-
2021
- 2021-05-21 US US17/327,551 patent/US12318388B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018046174A1 (en) | 2016-09-09 | 2018-03-15 | Universite De Liege | New use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112021012834A2 (pt) | 2021-09-28 |
| JP7588859B2 (ja) | 2024-11-25 |
| DK3955929T3 (da) | 2024-08-05 |
| US20210290625A1 (en) | 2021-09-23 |
| WO2020212553A1 (en) | 2020-10-22 |
| AU2020258017A1 (en) | 2021-07-01 |
| KR20220003556A (ko) | 2022-01-10 |
| ES2981773T3 (es) | 2024-10-10 |
| JP2022529052A (ja) | 2022-06-16 |
| CN113329753A (zh) | 2021-08-31 |
| AU2020258017B2 (en) | 2025-05-29 |
| EP3955929B1 (en) | 2024-05-15 |
| US12318388B2 (en) | 2025-06-03 |
| CN113329753B (zh) | 2024-08-13 |
| CA3128304A1 (en) | 2020-10-22 |
| EP3955929A1 (en) | 2022-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102678805B1 (ko) | 박테리아 감염의 예방 및 치료를 위한 피리미딘 유도체 | |
| JP5657642B2 (ja) | リバースターン類似体の新規な化合物およびその製造方法と用途 | |
| WO2006095906A1 (ja) | 複素環式化合物を有効成分とする免疫抑制剤及び抗腫瘍剤 | |
| HU230158B1 (hu) | Összekapcsolt glikopeptid-kefalosporin antibiotikumok | |
| JP2019506365A (ja) | アミノ金ホスフィン錯体に基づいた抗菌化合物 | |
| JP2019502667A (ja) | 抗菌化合物 | |
| JP7588859B2 (ja) | グラム陰性細菌の感染、汚染、及びファウリングを予防及び治療するための新規ピリミジン誘導体 | |
| CA3128304C (en) | Pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling | |
| US20230008368A1 (en) | Imidazoquinoline substituted phosphoric ester agonist, and preparation therefor and application thereof | |
| WO2017093544A1 (en) | Alkynyl phosphine gold complexes for treating bacterial infections | |
| US20190016730A1 (en) | Treatment of h. pylori infections using mtan inhibitors | |
| CA3090945C (en) | Pyrimidine derivatives for prevention and treatment of bacterial infections | |
| BR112020009290B1 (pt) | Derivados de pirimidina, seu método de preparação e seu uso, composição farmacêutica, e método ex vivo para matar ou impedir o crescimento bacteriano na formação de biofilme | |
| US20220143226A1 (en) | Use of triazolo[4,5-d]pyrimidine derivatives | |
| JP7354246B2 (ja) | ピロロピリミジン骨格を有する新規なリン酸エステル化合物又はその薬学的に許容可能な塩 | |
| US20230310481A1 (en) | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| Q13 | Ip right document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE) |